Vertex Pharmaceuticals Inc
VRTX
$445.82-4.45 (-0.99%)
Jun 25, 2025, 4:00 PM
Financials
| 52Week High | 519.88 | 52Week Low | 377.85 |
| Beta | 0.44 | Current Ratio Annual | 2.69 |
| Current Ratio Quarterly | 2.65 | Gross Margin TTM | 86.03 |
| Market Cap | 115.14B | Net Profit Margin TTM | -8.91 |
| Operating Margin TTM | -6.69 | Price To Book | 6.98 |
| Price To Free Cash Flow TTM | 44.76 | Price To Sales TTM | 10.37 |
| Quick Ratio Annual | 2.23 | Quick Ratio Quarterly | 2.13 |
| Return On Assets TTM | -4.51 | Return On Equity TTM | -6.25 |
| Return On Investment TTM | -6.18 | Revenue Growth3Y | 13.31 |
| Revenue Growth5Y | 21.50 | Revenue Growth Quarterly Yoy | 2.96 |
| Revenue Growth TTMYoy | 8.98 | Revenue Per Share TTM | 42.77 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 1534 | 4 | 2 | 10 | 18 | 5 | 238.84M | $91.47B |
| Mar 31, 2025 | 1521 | 181 | 169 | 595 | 547 | 175 | 240.63M | $109.34B |
| Change | 13(1%) | 177(4425%) | 167(8350%) | 585(5850%) | 529(2939%) | 170(3400%) | 1.79M(1%) | $17.87B(20%) |